The new face of genomics
Prominent US genomics Robert L. Strausberg, who directs the National Cancer Institute's (NCI) Cancer Genomics office, has been named as vice president for research at The Institute for Genomic Research (TIGR).
Prominent US genomics Robert L. Strausberg, who directs the National Cancer Institute's (NCI) Cancer Genomics office, has been named as vice president for research at The Institute for Genomic Research (TIGR).
Strasbourg, France-based Aventis has announced its intention to sell off part of its remaining stake in Rhodia, its loss-making former specialty chemicals subsidiary. The move reduces its stake in Rhodia to 15.3 per cent from 25.2 per cent, with the...
Engineers in the US are one step closer to mass-producing therapeutic proteins needed by today's pharmaceutical industry. Researchers claim to have achieved a major milestone in their efforts to effectively produce human therapeutics using a...
The biotechnology industry in the state of British Columbia in Canada could double the number of companies, attract large revenue-generating biotechnology firms and create more than 5,000 new jobs within five years, says a strategic report presented...
A prominent US law professor from Stanford University has called for an international treaty on sharing scientific and technological information, to be based on the arrangements already agreed for free trade under the World Trade Organisation (WTO)...